It would be suggested that both MVP and IGF-1R increase proliferation by activation of Src, PTEN, ERK and inhibit apoptosis through the ATM COP1/P53 axis, resulting in tumour resistance to DNA damage agents. This evidence concerns the gene SRC and neoplasm.